New York Senate Bill S04639

New York 2025-2026 Regular Session

• Introduced: 2/10/25
• Refer: 2/10/25
• Refer: 1/7/26

Caption

Relates to reporting on funds received pursuant to a New York opioid settlement sharing agreement.

Summary

This bill amends the Mental Hygiene Law to expand and clarify annual reporting requirements for opioid settlement funding. It requires the relevant commissioners to submit a consolidated public dashboard each year detailing baseline funding levels for entities receiving opioid settlement money, how those funds were used in the prior calendar year, who received the money, what services or programs were supported, the criteria used to make awards, and an analysis of program effectiveness using evidence-based uniform metrics. The reporting would also cover funds received under a New York opioid settlement sharing agreement, not just money deposited directly into the opioid settlement fund. The bill also broadens the law governing settlement-related litigation by extending the existing limitation on government entities bringing claims against parties released in statewide opioid settlement agreements. It specifies that no government entity may assert released claims against entities covered by a statewide opioid settlement agreement executed on or after June 1, 2021, and it clarifies that actions filed after June 30, 2019 against manufacturers, distributors, dispensers, consultants, or related parties that are later released are extinguished by operation of law. The act takes effect immediately.

Impact

The bill would primarily affect the Mental Hygiene Law’s opioid settlement oversight provisions by expanding transparency and accountability requirements for the use of settlement proceeds. It would require more detailed public reporting on allocations, recipients, services funded, and outcomes, and it would explicitly include funds distributed through opioid settlement sharing agreements. It would also reinforce the legal finality of statewide opioid settlements by barring or extinguishing certain released claims against opioid industry defendants and related parties, thereby limiting local or other government litigation once claims are released in a statewide agreement.

Sentiment

Based on the bill text and the absence of recorded committee debate or votes, the measure appears to be framed as an oversight and accountability bill with a generally administrative, non-controversial purpose. Its emphasis on public dashboards, evidence-based metrics, and preventing supplanting of existing funding suggests support for transparency and responsible use of opioid settlement dollars. No formal voting history or transcript comments are available to indicate opposition or support from specific legislators.

Contention

The main point of potential contention is the litigation-preclusion language, which limits government entities’ ability to pursue claims that have been released in statewide opioid settlement agreements and extinguishes certain pending actions by operation of law. That provision could be viewed as protecting settlement finality and avoiding duplicative lawsuits, but it may also concern local governments or advocates who prefer broader authority to pursue opioid-related claims. A second possible area of concern is whether the reporting requirements are sufficiently detailed and whether the added administrative burden on agencies and recipients is justified, though the bill’s overall thrust is transparency rather than restriction.